Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/24/23 19:33 | 8/23/23 | SEER | Electr | LabEq | Laboratory Analytical Instrum | Farokhzad Omid | CA | DO | CEO,P,Ch | P | 98 | 2.45 | 0 | 40 | 5 | 808 | D | ||||||||||||||
12/31/20 20:18 | 12/8/20 | SEER | Electr | LabEq | Laboratory Analytical Instrum | Ainslie Lee S III | NY | T | P.a | 1,774 | 19.00 | 0 | 93 | 23 | I | ||||||||||||||||
12/10/20 16:15 | 12/8/20 | SEER | Electr | LabEq | Laboratory Analytical Instrum | Invus Public Equities, L.P. | NY | T | P.d | 15,010 | 19.00 | 0 | 790 | 16 | 5,841 | D | |||||||||||||||
12/10/20 16:15 | 12/8/20 | SEER | Electr | LabEq | Laboratory Analytical Instrum | Amoon 2 Fund Limited Partnership | L3 | T | P.dm | 16,900 | 19.00 | 0 | 889 | 18 | 5,923 | M | |||||||||||||||
12/9/20 20:23 | 12/8/20 | SEER | Electr | LabEq | Laboratory Analytical Instrum | McGuire Terrance | CA | D | P.d | 1,500 | 19.00 | 0 | 79 | New | 79 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |